What are the side effects of brukinsa?

What are the potential side effects of Brukinsa?

Brukinsa (zanubrutinib) is a medication used to treat certain types of blood cancers, including mantle cell lymphoma and Waldenström macroglobulinemia. Like all medications, Brukinsa can cause side effects, some of which can be serious [1].

Common side effects:

According to the FDA approval label, the most common side effects of Brukinsa include:

* Diarrhea (22-44% of patients)
* Nausea (20-38% of patients)
* Fatigue (17-34% of patients)
* Edema (17-34% of patients)
* Vomiting (15-29% of patients)
* Cough (14-26% of patients)
* Rash (14-26% of patients)

Serious side effects:

Brukinsa may cause serious side effects, including:

* Atrial fibrillation (irregular heartbeat) (up to 15% of patients)
* Cardiac arrhythmias (up to 14% of patients)
* Increased risk of bleeding (up to 13% of patients)
* Increased risk of infections (up to 12% of patients)

Other side effects:

Brukinsa can also cause other side effects, including:

* Headache (up to 12% of patients)
* Muscle pain (up to 11% of patients)
* Weakness (up to 10% of patients)
* Joint pain (up to 9% of patients)
* Back pain (up to 8% of patients)

Patient concerns:

Patients taking Brukinsa should be aware of the potential side effects and report any concerns to their healthcare provider. Additionally, patients should follow a healthy lifestyle, including maintaining a balanced diet, staying hydrated, and exercising regularly [2].

References:

1. [1] Food and Drug Administration. (2021). Brukinsa (zanubrutinib) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213144s000lbl.pdf
2. [2] FDA. (2022). Brukinsa (zanubrutinib) Tablets. Retrieved from https://www.drugs.com/sfx/brukinsa-side-effects.html

Note: You can check DrugPatentWatch.com for more information on Brukinsa, including patent information and research data [3].

Sources:
[1] Food and Drug Administration
[2] Patient Information
[3] DrugPatentWatch.com